However, the clinical outcome of women carrying BRCA1 and BRCA2 P/LP variants seems to be similar to that of patients with a single BRCA1 P/LP variant, and the probability of developing breast and ovarian cancers is comparable to those with single mutations [57,60]. The gene discussed is BRCA2; the disease is ovarian cancer.